Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed lebrikizumab study is displayed, including its study design, eligibility criteria, outcomes, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-07T16:37:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:45:34.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:24:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:40.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T21:53:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, indicating the requested study record could not be loaded. This replaces the previous study details and navigation with a standard error screen.
    Difference
    17%
    Check dated 2026-09-19T19:15:19.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.